Purdue Pharma

The OxyContin manufacturer has long been accused of ignoring the drug's addictive qualities in favor of profit.
HuffPost previously revealed that Amit Paley was part of a McKinsey consulting team for notorious OxyContin maker Purdue Pharma.
Amit Paley, CEO of The Trevor Project, was part of a team advising Purdue Pharma on how to boost sales of opioids during his time at McKinsey & Co., according to a trove of documents reviewed by HuffPost.
In three hours of emotional testimony, over two dozen people were able to directly confront the Purdue Pharma owners about the human toll of the crisis.
Roughly 20 people whose lives and families have been wracked by opioid abuse will give statements in U.S. Bankruptcy Court with some Sackler family members listening.
States agreed to sign on after the Sacklers kicked in more cash and accepted other terms, including apologizing.
“This is a seismic victory for justice and accountability that will re-open the deeply flawed Purdue bankruptcy," Connecticut's attorney general said.
The Sackler family will give up ownership of the company and contribute $4.5 billion but will be freed from any future lawsuits over opioids.
A U.S. bankruptcy judge is expected to rule on whether the OxyContin maker will settle thousands of lawsuits.
The Sackler family, which profited off the epidemic with the painkiller OxyContin, is seeking to settle thousands of lawsuits in exchange for future legal immunity.